• Info
  • Insider Ownership

Insider Trading & Ownership of Motif Pharmaceuticals Ltd.

Location
Dublin, Ireland
Summary
The estimated value of insider holdings of Motif Pharmaceuticals Ltd. is at least $2,259,235 dollars as of 15 Feb 2024. Motif Pharmaceuticals Ltd. is the 10%+ Owner of Chromocell Therapeutics Corp and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $2.26M.
Signature
Motif Pharmaceuticals Ltd., By /s/ Zachary Klein
All Insider Reports
All Insider Reports

Notify me when Motif Pharmaceuticals Ltd. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Motif Pharmaceuticals Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTHS Chromocell Therapeutics Corp 10%+ Owner $2,259,235 15 Feb 2024

There are no insider transactions reported by Motif Pharmaceuticals Ltd.